Leveraging Behavioral Science to Improve Medicine Optimization Conversations With Older Adults
NCT ID: NCT06698770
Last Updated: 2025-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2420 participants
INTERVENTIONAL
2024-11-01
2025-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Psychological and Clinical Factors That Predict Intent to Deprescribe Medications Among Older Adults
NCT04676282
Older Adults' Attitudes Towards Stopping Aspirin
NCT07305376
Population Health Approach to Optimizing Medications in Older Adults
NCT06110156
Older Adults' Readiness to Stop Prescribed Medications
NCT05996237
Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
NCT00279656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Start medication - Lower chance of future health problems
Participants read a hypothetical scenario where a doctor recommends starting a new medication to lower their chances of experiencing significant health problems.
Anticipated long-term use of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.
Period re-evaluation of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.
Start medication - Higher risk without medication
Participants read a hypothetical scenario where a doctor recommends starting a new medication because they could experience a higher risk of serious health problems without it
Anticipated long-term use of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.
Period re-evaluation of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.
Stop medication - Lack of benefit
Participants read a hypothetical scenario where a doctor suggests stopping the medication due to a lack of benefit.
Anticipated long-term use of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.
Period re-evaluation of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.
Stop medication - Potential for harm
Participants read a hypothetical scenario where a doctor suggests stopping the medication due to the potential for harm.
Anticipated long-term use of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.
Period re-evaluation of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anticipated long-term use of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life.
Period re-evaluation of medication
In this hypothetical scenario, the doctor anticipates that the participant will take this medication for the rest of their life but will periodically re-evaluate the benefits and risks of the medication.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sydney
OTHER
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vordenberg
Clinical Associate Professor of Clinical Pharmacy and Associate Chair, Clinical Pharmacy, College of Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00259517
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.